R&D TDA - 2026 Graduate Internship (Summer) at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Internship, Entry Level & New GradExperience Level
InternshipJob Type
UnknownVisa
PharmaceuticalIndustries

Requirements

  • Enrolled in an undergraduate program with a concentration in Biology, Chemistry, Biochemistry, Chemical Engineering, Biomedical Engineering, Mechanical Engineering, or a related discipline
  • Students must have at least one academic term remaining following the completion of the internship
  • Team player with excellent communication skills (preferred)

Responsibilities

  • Contribute to projects in areas such as bioassay development, biological testing of compounds, organic and peptide synthesis, chemical modality, molecular biology, protein expression, purification, characterization, analytical methods, and formulation, flow chemistry, project management, drug product design and performance, or drug product manufacturing process development
  • Actively contribute to the Discovery or Development organization
  • Build a comprehensive understanding of the pharmaceutical industry and the role of Eli Lilly and Company scientists in delivering innovative medicines to patients

Skills

Key technologies and capabilities for this role

bioassay developmentbiological testingorganic synthesispeptide synthesismolecular biologyprotein expressionpurificationcharacterizationanalytical methodsformulationflow chemistryproject management

Questions & Answers

Common questions about this position

What are the basic qualifications for this internship?

Candidates must be enrolled in an undergraduate program with a concentration in Biology, Chemistry, Biochemistry, Chemical Engineering, Biomedical Engineering, Mechanical Engineering, or a related discipline, and have at least one academic term remaining after the internship.

Where are the internship positions located?

The positions are located at the corporate headquarters in Indianapolis, IN, and may include other locations such as Boston, MA; New York City, NY; San Diego, CA; Pasadena, CA, South San Francisco, CA, and Louisville, CO.

When does the internship take place?

The internship is for the Summer of 2026 with start dates in May and June 2026.

What kind of projects might interns work on?

Projects may include bioassay development, biological testing of compounds, organic and peptide synthesis, chemical modality, molecular biology, protein expression, purification, characterization, analytical methods, formulation, flow chemistry, project management, drug product design, performance, and manufacturing process development.

What preferred skills are mentioned for this role?

Preferred skills include being a team player with excellent communication skills and previous laboratory or pharmaceutical research experience in areas like bioassay development, biological testing, organic and peptide synthesis, chemical modality, molecular biology, protein expression, or purification.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI